Ontology highlight
ABSTRACT:
SUBMITTER: Lee HC
PROVIDER: S-EPMC6142433 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature
Lee Hans C HC Weber Donna M DM
Hematology. American Society of Hematology. Education Program 20161201 1
The use of proteasome inhibitors and immunomodulatory agents in the treatment of myeloma have resulted in significant improvements in patient outcomes over the last decade. Although these agents now form the backbone of current myeloma treatment regimens both in the frontline and in a relapsed setting, drug resistance remains an inevitable challenge that most patients will encounter during their disease course. Hence, new treatment strategies continue to be explored, and the recent regulatory ap ...[more]